HB 233 takes positive steps toward updating Montana law to cover biologics and biosimilars in a way that protects patients. Unlike traditional chemical drugs, biologics are unique, complex structures made from living cells that are not easily replicated. A small change or difference in the biosimilar or biologic manufacturing process has the potential to adversely impact the patient. […]
FOR IMMEDIATE RELEASE MEDIA CONTACT Jessica Daitch Phone: 917-816-6712 Email: firstname.lastname@example.org Survey Finds Insurance Companies are Forcing Floridians Off Prescribed Medications During the Plan Year, Providing A Need for New Legislation to Fix the Problem Nearly all respondents (94%) support legislation prohibiting insurance companies from financially pressuring them to switch from their prescribed medication UPPER […]
Global Healthy Living Foundation’s Director of State and National Advocacy, Stephen Marmaras, recently was interviewed on the radio in Alaska to discuss recent biosimilar legislation and its implications for Alaskans.